News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
884,712 Results
Type
Article (88851)
Company Profile (816)
Press Release (795023)
Multimedia
Podcasts (241)
Webinars (35)
Section
Business (233627)
Career Advice (4164)
Deals (40006)
Drug Delivery (179)
Drug Development (91741)
Employer Resources (207)
FDA (18567)
Job Trends (17491)
News (398804)
Policy (40018)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3055)
Academic (2)
Accelerated approval (58)
ADA (49)
Adcomms (42)
Allergies (208)
Alliances (56990)
ALS (241)
Alzheimer's disease (1983)
Antibody-drug conjugate (ADC) (570)
Approvals (18937)
Artificial intelligence (894)
ASCO (345)
Autoimmune disease (367)
Automation (69)
Bankruptcy (409)
Best Places to Work (12635)
BIO (71)
BIOSECURE Act (23)
Biosimilars (250)
Biotechnology (481)
Bladder cancer (214)
Brain cancer (85)
Breast cancer (846)
Cancer (6679)
Cardiovascular disease (563)
Career advice (3600)
Career pathing (52)
CAR-T (390)
CDC (77)
Celiac Disease (3)
Cell therapy (1089)
Cervical cancer (56)
Clinical research (79187)
Collaboration (2419)
Commercialization (1)
Company closure (8)
Compensation (1542)
Complete response letters (107)
COVID-19 (3043)
CRISPR (127)
C-suite (1314)
Cystic fibrosis (168)
Data (8831)
Decentralized trials (3)
Denatured (92)
Depression (199)
Dermatology (99)
Diabetes (717)
Diagnostics (7617)
Digital health (71)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (447)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (321)
Earnings (102508)
Editorial (80)
Employer branding (25)
Employer resources (175)
Events (138844)
Executive appointments (1206)
FDA (22723)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (36)
Funding (1987)
Gene editing (275)
Generative AI (91)
Gene therapy (860)
GLP-1 (1291)
Government (5565)
Grass and pollen (8)
Guidances (423)
Healthcare (21269)
Hematology (198)
HIV (99)
Huntington's disease (67)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (360)
Immuno-oncology (116)
Indications (217)
Infectious disease (3451)
Inflammatory bowel disease (245)
Inflation Reduction Act (17)
Influenza (154)
Intellectual property (328)
Interviews (822)
IPO (18007)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (23)
Labor market (125)
Layoffs (691)
Leadership (54)
Legal (10171)
Liver cancer (111)
Longevity (38)
Lung cancer (882)
Lymphoma (483)
Machine learning (69)
Management (67)
Manufacturing (1261)
Marketing (2)
MASH (229)
Medical affairs (1)
Medical device (15293)
Medtech (15468)
Mergers & acquisitions (23317)
Metabolic disorders (1849)
mRNA (273)
Multiple sclerosis (209)
NASH (24)
Neurodegenerative disease (521)
Neuropsychiatric disorders (130)
Neuroscience (3769)
Neurotech (2)
NextGen: Class of 2026 (7716)
Non-profit (5147)
Now hiring (82)
Obesity (878)
Opinion (377)
Ovarian cancer (247)
Pain (288)
Pancreatic cancer (367)
Parkinson's disease (424)
Partnered (41)
Patents (668)
Patient recruitment (783)
Peanut (71)
People (68087)
Pharmaceutical (136)
Pharmacy benefit managers (38)
Phase 1 (24473)
Phase 2 (34404)
Phase 3 (25863)
Pipeline (10009)
Policy (402)
Postmarket research (3560)
Preclinical (10995)
Press Release (72)
Prostate cancer (353)
Psychedelics (73)
Radiopharmaceuticals (375)
Rare diseases (1291)
Real estate (7462)
Recruiting (81)
Regulatory (30503)
Reports (77)
Research institute (2773)
Resumes & cover letters (654)
Rett syndrome (44)
RNA editing (30)
RSV (100)
Schizophrenia (197)
Series A (341)
Series B (247)
Service/supplier (28)
Sickle cell disease (129)
Special edition (32)
Spinal muscular atrophy (191)
Sponsored (55)
Startups (4374)
State (2)
Stomach cancer (21)
Supply chain (149)
Tariffs (104)
The Weekly (146)
Vaccines (1317)
Venture capital (140)
Weight loss (601)
Women's health (144)
Worklife (25)
Date
Today (137)
Last 7 days (512)
Last 30 days (2862)
Last 365 days (33209)
2026 (17075)
2025 (33218)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1297)
Alabama (102)
Alaska (7)
Arizona (409)
Arkansas (16)
Asia (52368)
Australia (9201)
California (14531)
Canada (4058)
China (1611)
Colorado (625)
Connecticut (647)
Delaware (450)
Europe (120746)
Florida (2172)
Georgia (471)
Hawaii (4)
Idaho (70)
Illinois (1270)
India (105)
Indiana (672)
Iowa (26)
Japan (612)
Kansas (144)
Kentucky (57)
Louisiana (64)
Maine (89)
Maryland (1755)
Massachusetts (10645)
Michigan (427)
Minnesota (811)
Mississippi (7)
Missouri (165)
Montana (37)
Nebraska (31)
Nevada (155)
New Hampshire (92)
New Jersey (3854)
New Mexico (35)
New York (3825)
North Carolina (1952)
North Dakota (11)
Northern California (7228)
Ohio (455)
Oklahoma (27)
Oregon (55)
Pennsylvania (2853)
Puerto Rico (33)
Rhode Island (55)
South America (1668)
South Carolina (89)
South Dakota (2)
Southern California (5711)
Tennessee (234)
Texas (2377)
United States (52013)
Utah (434)
Vermont (2)
Virginia (375)
Washington D.C. (89)
Washington State (1192)
West Virginia (4)
Wisconsin (160)
Wyoming (2)
There are 884,712 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Lilly deepens relationship with China’s Abbisko for $1.9B biobucks
Lilly has already spent more than $25 billion in potential business development commitments this year, including the $6.3 billion buyout of Centessa Pharmaceuticals that closed today.
June 24, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Verici Dx Receives New York State Approval, Establishing Nationwide Access to Tutivia™ Kidney Transplant Rejection Test
June 24, 2026
·
6 min read
Press Releases
CEL-SCI and Saudi Amarox Hold Strategic Agreement Signing Ceremony at BIO 2026, Advancing U.S.–Saudi Cooperation in Cancer Care
June 24, 2026
·
5 min read
Press Releases
Modular Medical Announces Commercial Availability of Pivot Tubeless Insulin Patch Pump Ahead of Commercial Expansion
June 24, 2026
·
4 min read
Press Releases
Cadrenal Therapeutics Announces Selection of CAD-1005 Phase 2 Study for Late-Breaking Oral Presentation at ISTH 2026 Congress
June 24, 2026
·
6 min read
Press Releases
Picard Medical Announces Leadership Transition
June 24, 2026
·
5 min read
Press Releases
Calidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit
June 24, 2026
·
5 min read
Press Releases
AIM ImmunoTech Accelerates Toward Potential Pivotal Pancreatic Cancer Program as Ampligen Continues to Advance Through Key Clinical Milestones
June 24, 2026
·
9 min read
Press Releases
Model Medicines to Present Data on Two First-in-Class Programs Ahead of Catalyst Regulatory Filings at the 2026 BIO International Convention in San Diego
CEO Daniel Haders, PhD, will highlight upcoming catalyst events for the company’s two lead assets: MDL-001, a first-in-class, universal, direct-acting therapeutic for influenza-like-illness (ILI) and chronic hepatitis, targeting the novel RdRp Thumb-1 site, and MDL-4102, a first-in-class therapeutic for various cancers and inflammatory diseases, targeting the epigenetic reader and master regulator of gene transcription, BRD4.
June 24, 2026
·
1 min read
Press Releases
Phio Pharmaceuticals Reaches Key Milestone in Advancing Lead Candidate PH-762
Nitto Denko Avecia begins first commercial-scale cGMP production of PH-762 drug substance Newly manufactured supply will support upcoming clinical trial in next development phase
June 24, 2026
·
5 min read
1 of 88,472
Next
